ProQR Therapeutics N.V. Ordinary Shares

PRQRNASDAQUSD
1.97 USD
0.14 (7.65%)AT CLOSE (11:59 AM EDT)
1.98
0.01 (0.25%)
POST MARKET (AS OF 04:54 PM EDT)
Post Market
AS OF 04:54 PM EDT
1.98
0.01 (0.25%)
🟢Market: OPEN

PRQR is currently priced at $1.98. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9 and a bearish Death Cross on the long-term moving averages.

Technical & fundamental data as of Aug 5, 2026.

Open?$1.88
High?$1.98
Low?$1.85
Prev. Close?$1.83
Volume?1.3M
Avg. Volume?N/A
VWAP?$1.92
Bid / Ask
Bid?$1.67 × 100
Ask?$2.24 × 100
Spread?$0.57
Midpoint?$1.96
Valuation & Ratios
Market Cap?241.3M
Shares Out?105.4M
Float?86.8M
Float %?82.4%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
Employees
187
Market Cap
241.3M
Industry
N/A
Listed
2014-09-18
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
54
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.17Distress
Confidence?43%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?2.66%Low
Short Interest?2.3M
Days to Cover?1.8
Free Float86.8M
Avg Daily Volume1.3M
Settlement Date2026-07-15